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Epigenetic mechanisms have been proposed to
play crucial roles in mammalian development, but
their precise functions are only partially understood.
To investigate epigenetic regulation of embryonic
development, we differentiated human embryonic
stem cells into mesendoderm, neural progenitor
cells, trophoblast-like cells, and mesenchymal stem
cells and systematically characterized DNA
methylation, chromatin modifications, and the tran-
scriptome in each lineage. We found that promoters
that are active in early developmental stages tend to
be CG rich and mainly engage H3K27me3 upon
silencing in nonexpressing lineages. By contrast,
promoters for genes expressed preferentially at later
stages are often CG poor and primarily employ DNA
methylation upon repression. Interestingly, the early1134 Cell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc.developmental regulatory genes are often located
in large genomic domains that are generally devoid
of DNA methylation in most lineages, which we
termed DNA methylation valleys (DMVs). Our results
suggest that distinct epigenetic mechanisms regu-
late early and late stages of ES cell differentiation.INTRODUCTION
Embryonic development is a complex process that remains to be
understood despite knowledge of the complete genome se-
quences of many species and rapid advances in genomic tech-
nologies. A fundamental question is how the unique gene
expression pattern in each cell type is established and main-
tained during embryogenesis. It is well accepted that the gene
expression program encoded in the genome is executed by tran-
scription factors that bind to cis-regulatory sequences and
modulate gene expression in response to environmental cues
(Young, 2011). Growing evidence now shows that maintenance
of such cellular memory depends on epigenetic marks such as
DNA methylation and chromatin modifications (Bird, 2002; Kou-
zarides, 2007).
DNA methylation at promoters has been shown to silence
gene expression and thus has been proposed to be necessary
for lineage-specific expression of developmental regulatory
genes, genomic imprinting, and X chromosome inactivation
(Bird, 2002). Indeed, the DNA methyltransferases DNMT1 or
DNMT3a/3b double-knockout mice exhibit severe defects in
embryogenesis and die before midgestation, supporting an
essential role for DNA methylation in embryonic development
(Li et al., 1992; Okano et al., 1999). On the other hand, mouse
embryonic stem cells (mESCs) lacking all three DNMTs can sur-
vive and self-renew and can even begin to differentiate to some
germ layers (Jackson et al., 2004; Tsumura et al., 2006), raising
the possibility that DNA methylation is dispensable for at least
initial lineage specification in early embryos. Thus, the role of
DNA methylation in animal development needs to be more pre-
cisely defined. Like DNA methylation, chromatin modifications
have also been shown to play a key role in animal development.
Enzymes responsible for methylation of histone H3 at lysine 4, 9,
and 27, in particular, are essential for embryogenesis (Kouzar-
ides, 2007; Vastenhouw and Schier, 2012). Additionally, deple-
tion of the histone acetyltransferase p300 or CBP also leads to
early embryonic lethality (Yao et al., 1998). Although both DNA
methylation and chromatinmodifications are critical for mamma-
lian development, the exact role of each epigenetic mark in the
maintenance of lineage-specific gene expression patterns re-
mains to be defined.
In humans, studying the epigenetic mechanisms regulating
early embryonic development often requires access to embry-
onic cell types that are currently difficult or impractical to obtain.
Human embryonic stem cells (hESCs) (Thomson et al., 1998) can
be differentiated into a variety of precursor cell types, providing
an in vitromodel system for studying early human developmental
decisions. We have established protocols for differentiation of
hESCs to various cell states, including trophoblast-like cells
(TBL) (Xu et al., 2002), mesendoderm (ME) (Yu et al., 2011), neu-
ral progenitor cells (NPCs) (Chambers et al., 2009; Chen et al.,
2011), and mesenchymal stem cells (MSCs) (Vodyanik et al.,
2010). The first three states represent developmental events
that mirror critical developmental decisions in the embryo (the
decision to become embryonic or extraembryonic, the decision
to become mesendoderm or ectoderm, and the decision to
become surface ectoderm or neuroectoderm, respectively).
MSCs are fibroblastoid cells that are capable of expansion and
multilineage differentiation to bone, cartilage, adipose, muscle,
and connective tissues (Vodyanik et al., 2010). The specific
hESC derivatives chosen thus reflect key lineages in the human
embryo and also represent those lineages that currently can be
produced in sufficient quantity and purity for epigenomic
studies. These lineages will complement other cells from more
mature sources, many of which have had their epigenomes
well characterized (Hawkins et al., 2010; Lister et al., 2009; Zhu
et al., 2013). Importantly, epigenomic analysis of these cell types
allows for investigation of chromatin and transcriptional changes
that drive the initial developmental fate decisions.Here, we used high-throughput approaches to examine
the differentiation of hESCs into four cell types by generating
in-depth maps of transcriptomes, a large panel of histone mod-
ifications, and base-resolution maps of DNA methylation for
each cell type. Our study provided a full view of the dynamic epi-
genomic changes accompanying cellular differentiation and line-
age specification. As outlined below, an integrative analysis of
these data sets provided us with substantial insights into the
role of DNA methylation and chromatin modifications in animal
development.
RESULTS
Generation of Comprehensive Epigenome Reference
Maps for hESCs and Four hESC-Derived Lineages
Wedifferentiated the hESC line H1 toME, TBL, NPCs, andMSCs
(Figure 1A) (Extended Experimental Procedures). ME, TBL, and
NPC differentiation occurred quickly (2 days, 5 days, and
7 days, respectively) compared to that of MSC (19–22 days).
The expression of various marker genes in these cells was
confirmed using immunofluorescence and fluorescence-acti-
vated cell sorting (FACS), and the purity of each cell population
ranged from 93% to 99% (Figures S1A–S1C available online).
ME, NPCs, and MSCs possess further differentiation potentials
as shown in Figures S1D and S1E (for ME and NPCs) and our
previous study (for MSCs) (Vodyanik et al., 2010). On the other
hand, the nature of TBL is still currently under debate (Bernardo
et al., 2011; Xu et al., 2002). As a control for terminally differenti-
ated cells, we also cultured and analyzed IMR90, a primary hu-
man fetal lung fibroblast cell line. For each cell type, we mapped
DNA methylation at base resolution using MethylC-seq (Lister
et al., 2009) (20–353 total genome coverage or 10–17.53
coverage per strand). We also mapped the genomic locations
of 13–24 chromatin modifications by chromatin immunoprecipi-
tation sequencing (ChIP-seq). Additionally, we performed
paired-end (100 bp 3 2) RNA-seq experiments, generating
more than 150 million uniquely mapped reads for every cell
type (Figures 1A and 1B). At least two biological replicates
were carried out for each analysis, and the data were publicly
released as part of the NIH Roadmap Epigenome Project
(http://www.epigenomebrowser.org/). Selected data are also
available at http://epigenome.ucsd.edu/differentiation.
Identification of Differentially Expressed Genes in
hESC-Derived Cells
We first asked how the genome is differentially transcribed when
hESCs are differentiated into each cell type. To do so, we exam-
ined the expression of 19,056 RefSeq coding genes (33,797 iso-
forms), among which 76.6% (14,595) were expressed in at least
one cell type (Figure S2A). Using an entropy-basedmethod (Bar-
rera et al., 2008; Schug et al., 2005) (Figure S2B), we identified
2,408 genes that showed cell-type-specific expression (Figures
2A and S2A). For convenience, we use ‘‘lineage-restricted
genes’’ to reflect both H1-specific and differentiated cell-spe-
cific genes. As expected, known lineagemarkers were highly ex-
pressed in the corresponding cell types (Figure 2A). It is worth
noting that, in line with a previous report (Yu et al., 2011), the
ME cells also express high levels of the hESC regulatorsCell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc. 1135
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Figure 1. Generation of Comprehensive
Epigenome Reference Maps for hESCs and
Four hESC-Derived Lineages
(A) Schematic of hESC differentiation procedures
and a summary of the epigenomic data sets pro-
duced in this study.
(B) A snapshot of the UCSC genome browser
shows the DNAmethylation level (mCG/CG), RNA-
seq reads (+, Watson strand; , Crick strand),
and ChIP-seq reads (RPKM) of 24 chromatin
marks in H1.
See also Figure S1.NANOG, POU5F1, and a reduced but significant level of SOX2.
We then investigated a cohort of long noncoding RNA (lncRNA)
genes and detected significant levels of transcripts for 2,175
known and 281 unannotated lncRNA genes in at least one cell
type (Figures 2A and S2A). Using the same entropy-based
approach, we found 930 lncRNA genes defined as lineage
restricted (Figure S2C), which constitute 37.9% of total ex-
pressed lncRNA genes. By contrast, only 16.5% of expressed
coding genes are characterized as lineage restricted (Fig-
ure S2D). The above analysis defined a large number of coding
and noncoding genes that are differentially expressed in H1
and its derived cells. The lists of all lineage-restricted genes
are included in Table S1.
Intriguingly, the promoters of several lncRNA genes highly
expressed in H1 overlap with the long terminal repeat (LTR)-
containing retrotransposons (Figure 2B). This appears to be a
general phenomenon as we observed that significant percent-
ages of transcription start sites (TSSs) of lncRNA genes directly
fall into LTRs (Figure 2C). The percentages are notably higher for
H1- and ME-enriched lncRNA genes (30% and 31%, respec-
tively), which are in contrast to those of coding genes (<2%).
By quantifying the transcription levels of all major classes of
mappable repetitive elements, we found that the ERV1 (class I
endogenous retrovirus) elements are preferentially expressed
in H1 and ME, but not in other cell types (Figure 2D, top). Strik-
ingly, such lineage-specific expression occurs almost exclu-1136 Cell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc.sively at the ERV1 subfamily HERV-H
and its flanking LTR elements LTR7 (Fig-
ure 2D, bottom). Together, HERV-H and
LTR7 account for more than 43% of
LTRs that are present at H1- andME-spe-
cific lncRNA gene promoters. A gene
ontology analysis of coding genes near
H1-specific HERV-H/LTR7 sites revealed
an enrichment of POU5F1-targeted
genes (p value = 4 3 1015), which is
consistent with a previous study showing
that NANOG and POU5F1 preferentially
bind to repetitive elements (Kunarso
et al., 2010). We did not find significant
enrichment of LTR subclasses for other
lineage-restricted lncRNA genes. Repeti-
tive elements are known to be regulated
by DNA methylation and H3K9me3 inESCs (Leung and Lorincz, 2012). We do not find significant
enrichment of H3K9me3 around most HERV-H elements (data
not shown). By contrast, a subset of the H1-specific HERV-H
elements (n = 70) show hypomethylation in H1 and ME but
gain DNA methylation in other H1-derived cells (Figures 2B and
2E). Notably, the overall low level of DNA methylation in IMR90
reflects its globally hypomethylated genome, likely due to the
presence of partially methylated domains (PMDs) (Figures S2E
and S2F) (Lister et al., 2009). Additionally, by examining pub-
lished methylomes (Lister et al., 2011), we found that DNA
methylation at these regions was depleted upon reprogramming
of IMR90 or foreskin fibroblasts to iPSCs and was then reestab-
lished when the fibroblast-derived iPSCs were differentiated to
trophoblast-like lineage (Figure 2B). Together, these data sug-
gest that many noncoding RNA genes may be transcriptionally
regulated by endogenous retroviral sequences. Of particular in-
terest, the expression of HERV-H/LTR7 is closely correlated with
the state of pluripotency and may be regulated by DNA
methylation.
Dynamic DNA Methylation and Chromatin Modifications
at Promoters of Lineage-Restricted Transcripts
Previous studies have shown that the promoters for somatic-tis-
sue-specific genes are often CG poor and lack CpG islands
(CGIs), in contrast to those for housekeeping genes, which
are CG rich and predominantly contain CGIs (Barrera et al.,
AB
E
C
D
Figure 2. Identification of Lineage-Restricted Transcripts in H1 and H1-Derived Cells
(A) Heatmaps showing the expression levels of lineage-restricted coding genes (left) and lncRNA genes (right). Genes are organized by the lineage in which their
expression is enriched. Note that certain genes (such as SOX2) can be expressed in more than one cell type.
(B) The levels of DNA methylation and RNA, as well as the binding of NANOG, SOX2, and POU5F1, are shown around an annotated lincRNA gene with the
promoter overlapping a HERV-H element.
(C) The percentages of TSSs that overlap with LTRs are shown for coding genes (yellow) and lncRNA genes (blue) for all genes (total) or lineage-restricted genes.
(D) The numbers of expressed (FPKMR 1), mappable repetitive elements are shown in each cell type for various repeat classes (top) or subclasses of ERV1
(bottom). Data are represented as mean ± SD based on two replicates of RNA-seq.
(E) The average DNA methylation level in each cell type is shown for a subset of H1-specific HERV-H elements.
See also Figure S2.2008; Schug et al., 2005). Therefore, we asked whether early
lineage-restricted promoters also demonstrate similar features
as tissue-specific promoters. We first identified promoters for
each lineage-restricted gene and excluded those with ambig-
uous active promoters (Extended Experimental Procedures).
Next, we divided the promoters into three groups based on CG
density (high, medium, and low) (Figure S3A). Surprisingly, genes
preferentially expressed in early embryonic lineages H1,ME, andNPC tend to be CG rich and contain CGIs (Figure 3A). The per-
centages of CGI-containing promoters decreased for genes en-
riched in MSCs and IMR90, which are at relatively late develop-
ment stages. By contrast, a much lower percentage of
promoters (23%) contain CGIs for somatic-tissue-specific genes
identified from 18 human tissues (Zhu et al., 2008) (Figure 3A).
We further verified this using an independent set of somatic-tis-
sue-specific genes (35%) (Chang et al., 2011). These dataCell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc. 1137
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Figure 3. Epigenetic Regulation of Promoters for Lineage-Restricted Genes
(A) Bar graphs showing the percentages of promoters in the high, medium, and low CG classes for genes that are enriched in each cell type, all RefSeq genes,
housekeeping genes, and somatic-tissue-specific genes identified in Zhu et al. (2008). The percentages of promoters that contain CGIs are also shown (blue line).
(B) Heatmaps showing the average levels of RNA, H3K27ac, H3K4me3, H3K27me3, and DNA methylation for promoters of lineage-restricted genes. Histone
modifications, TSS ± 2 kb; DNA methylation, TSS ± 200 bp; promoter CG density, TSS ± 500 bp.
(C) Bar graphs showing the percentages of promoters that are marked by DNA methylation or K27me3 in at least one cell type.
(D–F) The levels of RNA, DNA methylation, and K27me3 are shown for the locus containing T (D), POU5F1 (E), or PIPOX (F). PIPOX (black arrow) is a low CG-
promoter-containing gene located in a K27me3 domain in MSCs and IMR90, where it is also repressed.
(G) The distribution of Pearson correlation coefficients between gene expression level and the levels of various histone modifications or DNA methylation at
promoters.
See also Figure S3.
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suggest that the promoters used for lineage specification in early
stages of cell differentiation have distinct sequence features
compared to those in more mature cell types.
DNA methylation machinery has been shown to be a mecha-
nism of gene silencing during cell differentiation (Bird, 2002). In
addition, the Polycomb protein complex, which deposits
H3K27me3 at target genes, can also repress developmental
genes (Boyer et al., 2006; Lee et al., 2006). We set to determine
which promoters are subject to regulation by DNA methylation,
H3K27me3, or both. A detailed analysis showed that promoters
with high CG density tend to be enriched for H3K27me3,
whereas those with low CG density are preferentially marked
by DNA methylation (Figures 3B and 3C). This is exemplified
by the promoters of the ME marker T (high CG, with a CGI) and
the hESC marker POU5F1 (medium CG, no CGIs) (Figures 3D
and 3E). Notably, whereas both H3K27me3 and DNA methyl-
ation are largely anticorrelated with gene expression, high CG
promoters are often marked by reduced but significant enrich-
ment of H3K27me3 even when they are active (Figures 3B and
3D). It has been shown that the PRC2 complex can be directly
recruited by CG-rich sequences (Mendenhall et al., 2010).
Consistent with this model, our data indicate that the sequence
of a promoter could contribute to the epigenetic mechanisms
that affect its regulation.
Notably, the majority of developmental regulatory genes,
including SOX2, NODAL, EOMES, T, SOX17, and SOX1, belong
to the high CG group and are marked by H3K27me3 (Figure 3B).
DNA methylation, on the other hand, marks a relatively small
number of lineage-restricted genes, including NANOG and
POU5F1. A gene ontology analysis also showed that lineage-
restricted genes with high CG promoters are enriched for
developmental genes, embryonic morphogenesis, and pattern
specification, whereas those with low CG promoters contain
genes that function in plasma membrane, disulfite bond, and
protein kinase cascade. As controls, somatic-tissue-specific
promoters are largely CG poor, often showing high level of
DNA methylation; housekeeping gene promoters are predomi-
nantly CG rich, showing neither DNA methylation nor
H3K27me3 in these cells (Figure S3B). Interestingly, some CG-
poor promoters are also marked by low levels of H3K27me3.
These promoters are largely observed in the expanded
H3K27me3 domains (Figures 3B and 3F, black arrow), a broad
pattern of enrichment for H3K27me3 (Hawkins et al., 2010; Zhu
et al., 2013) that frequently occurs in MSCs and IMR90, but
less so in H1 and other H1-derived cells (Figure S3C and data
not shown). These observations suggest that the expansion of
H3K27me3 may be a mechanism to lock low CG promoters in
a repressed state in later development stages. Consistently,
H3K27me3 shows similar negative correlations with gene
expression in all three classes (Figure 3G). By contrast, DNA
methylation shows the strongest negative correlation with gene
expression for low CG genes (see Figure S3D for the analysis
of additional histone modifications). Together, our data suggest
that, although H3K27me3 may play a widespread role in regu-
lating key factors of cellular differentiation, DNA methylation is
involved in modulation of many somatic-tissue-specific genes
and a limited number of—albeit critical—developmental
regulators.Dynamic DNA Methylation and Chromatin Modifications
at Enhancers Reflect Lineage-Restricted Gene
Expression
Enhancers are distal regulatory elements that mediate tissue and
developmental-stage-specific gene expression (Ong and Cor-
ces, 2011). To examine the potential role of DNA methylation
and chromatin modifications at enhancers, we first identified a
total of 103,982 putative enhancer sites in the six cell types
(Table S2) by using an enhancer prediction method described
recently (Rajagopal et al., 2013) (Extended Experimental Proce-
dures). By examining the level of H3K27ac, a marker for active
enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011),
we classified 32,423 enhancers as lineage restricted using the
entropy-based analysis (Figure S4A, Table S2, and Extended
Experimental Procedures). We validated these enhancers using
several approaches by showing that they extensively overlap
with the binding sites of transcriptional regulators or DNase I
hypersensitive sites (J.A. Stamatoyannopoulos, personal
communication) (Figure S4B); they show evolutional conserva-
tion in sequences (Figure S4C); they are enriched for motifs of
transcription factors known to function in each lineage (Fig-
ure S4D and Table S3); and their neighboring genes demonstrate
functional enrichment that is related to their lineage identities
(Figure S4E). Finally, we constructed eight GFP reporters con-
taining various lineage-specific enhancers and injected them in
zebrafish embryos. A high percentage of these enhancers
(50%) demonstrated activity in vivo in specific lineages regard-
less of their positions relative to the reporter gene (Figure S4F).
Together, these data suggest that we have identified a set of line-
age-restricted enhancers of high quality in hESCs and hESC-
derived cells.
We subsequently examined the dynamic epigenetic modifica-
tions at lineage-restricted enhancers. As these modifications at
intragenic enhancers can be confounded by the activity of their
hosting genes, we focused on intergenic lineage-restricted en-
hancers (n = 6,819) for this analysis (enhancers present in
PMDs in IMR90 were also excluded). Most enhancers are CG
poor (94%) and appear to be depleted of H3K27me3 (Figure 4A).
However, weak enrichment of H3K27me3 is observed at a sub-
set of enhancers in MSCs and IMR90. These enhancers are
largely active in H1, ME, NPCs, and TBL, but not in MSCs and
IMR90, as indicated by the levels of H3K27ac. A closer examina-
tion revealed that these enhancers are preferentially present in
the H3K27me3 domains specific to MSCs and IMR90 (see Fig-
ure 4B for an example). In IMR90 and MSCs, repressed en-
hancers are marked by a higher level of H3K27me3 compared
to active enhancers (Figure 4C). By contrast, this is less evident
for enhancers in H1 and other H1-derived cells. These results are
consistent with the mode that the H3K27me3 domains that arise
in differentiated cells may function to repress enhancers that are
active in other lineages (Hawkins et al., 2010; Zhu et al., 2013).
Our data also showed that the presence of DNA methylation
negatively correlates with the activity of enhancers (Figure 4C).
Interestingly, although some H1-specific enhancers acquire
DNA methylation in MSCs and IMR90, this is less evident in
ME, NPCs, and TBL (Figures 4A and 4D). These data are in line
with a recent study showing that inactive regulatory elements
tend to progressively gain DNA methylation over time duringCell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc. 1139
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Figure 4. Epigenetic Regulation of Lineage-Restricted Enhancers
(A) Heatmaps showing the average levels of H3K27ac, H3K4me1, H3K4me3, H3K27me3, and DNA methylation around the centers of lineage-restricted
enhancers. Histone modifications, enhancer center ± 2 kb; DNA methylation, enhancer center ± 500 bp; CG density, enhancer center ± 500 bp.
(B) The epigenetic landscape at an intergenic locus showing a low level of H3K27me3 and absence of H3K27ac in MSC and IMR90.
(C) Box plots showing the levels of H3K27ac (top), H3K27me3 (middle), and DNA methylation (bottom) at active and repressed enhancers in each cell type.
(D) Scatterplots showing the levels of DNA methylation in each cell type at H1-specific enhancers (blue) and differentiated cell-specific enhancers (green). In the
last two panels, colon- and blood-specific enhancer information (green dots) is not available in Berman et al. (2012) and Li et al. (2010).
(E) Box plots showing the distribution of Pearson correlation coefficients between the levels of various histonemodifications or DNAmethylation at enhancers and
the expression level of their potential target genes.
See also Figure S4.
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cell differentiation (Bock et al., 2012). By contrast, differentiated
cell-specific enhancers appear highly methylated in lineages
where they are inactive. We do not observe significant differ-
ences between H1-specific and differentiated cell-specific en-
hancers in their proximity to the nearest TSSs (data not shown).
Notably, some H1-specific enhancers remain hypomethylated
even in MSCs, IMR90, and two human tissues: peripheral blood
mononuclear cells (Li et al., 2010) and the colon (mucosa) (Ber-
man et al., 2012) (Figure 4D). The functions of these hypomethy-
lated enhancers remain to be explored. Together, these data
indicate that H3K27me3 is preferentially enriched at a subset
of enhancers in a later stage of cellular differentiation. By
contrast, DNA methylation is widely present at enhancers of all
stages and negatively correlates with their activity.
We further examined whether the presence of DNA methyl-
ation or H3K27me3 may correlate with the expression of genes
that are potentially regulated by enhancers. To do so, we identi-
fied candidate target genes of lineage-restricted enhancers us-
ing correlative analyses (Ernst et al., 2011) (Table S4 and
Extended Experimental Procedures). At enhancers, histone
acetylation is generally positively correlated with the expression
of enhancer-targeted genes (Figures 4E and S4G). H3K27me3
and DNA methylation, by contrast, show an inverse relationship
with gene expression of their potential target genes. The analysis
results for expanded histone marks are included in Figure S4G.
Identification of DNA Methylation Valleys
Previously, low methylation regions (LMRs) and unmethylated
regions (UMRs) have been suggested to function as cis elements
(Stadler et al., 2011). Applying the same approach as Stadler
et al. (2011), we defined 5,323 to 31,158 UMRs and 32,744 to
74,541 LMRs in H1 and its derived lineages (Table S5). Indeed,
more than 85% of UMRs and 42% of LMRs are present in either
enhancers or promoters. Surprisingly, although LMR and UMRs
are generally short (median lengths 252 bp and 532 bp, respec-
tively), a number of loci show a much wider depletion of DNA
methylation. Interestingly, they often appear near genes for tran-
scription factors and developmental regulators. For example, a
9.3 kb hypomethylated region is observed at GSC, a transcrip-
tion factor specifically expressed in ME (Figure 5A). This unme-
thylated region covers the entire gene body and regions beyond,
which is in contrast to a typical UMR (CLMN, Figure 5A). We
sought to investigate whether such broad DNA methylation
depletion around developmental genes is a general phenome-
non. By examining all continuous hypomethylated regions in
H1 and the H1-derived cells (Figures S5A and 5B), we identified
those that are at least 5 kb long, which constitute less than 3.2%
of all hypomethylated regions in any cell type. We named these
regions DNA methylation valleys (DMVs). IMR90 was excluded
from this part of our study due to the presence of PMDs in these
cells (Lister et al., 2009) (Figure S2F), which would confound the
analyses. Genome wide, we identified 639, 1,004, 933, 944, and
962 DMVs in H1, ME, NPC, TBL, and MSC, respectively, among
which 461 are shared by all cell types (Figure 5C; see Table S6 for
the full lists). Together, these regions occupy 1,220 distinct
genomic loci. Strikingly, nearly every DMV (99.7%) contains at
least one known (89.9%) or putative promoter (9.8%, as indi-
cated by the presence of H3K4me3). The majority of DMVs(93.8%, n = 1,144) contain at least one CGI. Interestingly,
whereas 51.8% DMVs contain one or less CGI, 23.7% (289)
DMVs contain at least three CGIs (Figure S5B). These DMVs
range in size from 5 kb to 68 kb and are much larger than the
CGIs in these regions (Figure 5D). About 67% of DMVs contain
at least half non-CGI sequences even when we used a much
larger CGI list (n = 63,956) (Irizarry et al., 2009) instead of the
UCSC CGI list (n = 27,639). We then asked whether DMVs are
conserved across species. Indeed, DMVs show high level of
sequence conservation (Figure 5E). Additionally, we searched
for DMVs in mice using a brain methylome that we recently ob-
tained (Xie et al., 2012). Strikingly, a large number of genes
with DMVs in humans (638, or 59%, p value < 1 3 10100) are
also present in DMVs in mice (Figure 5F). Finally, many DMVs
(>40%) found in H1 and its derivatives were also observed to
be such in adult tissues (Berman et al., 2012; Li et al., 2010) (Fig-
ure S5C), suggesting that DMVs are not artifacts of cell culture.
The different numbers of DMVs in various cell types may be in
part attributed to variations in sequencing depth and methylome
coverage of promoters (Figure S5D).
Intriguingly, DMVs contain a unique set of genes. In total,
1,086 coding genes are found in the 1,220 DMVs (Table S7).
The majority (91.5%) of their promoters are CG rich (Figure S5E).
No significant differences in gene sizes are found for DMV genes
with CGIs compared to non-DMV genes with CGIs (data not
shown). Strikingly, a gene ontology analysis showed that these
genes are strongly enriched for functional groups in transcription
factors, homeobox family, developmental protein, and embry-
onic morphogenesis (Figure 5G). In fact, 38.4% (415) of coding
genes in DMVs encode DNA-binding proteins (Figure 5H). These
genes include hESC and lineage markers such as SOX2,
POU5F1, ZIC3 (hESC); EOMES, T, GSC (ME); GLI3, SIX3,
LHX3, PAX6 (NPC); GATA2, GATA6 (TBL); and RUNX1 (MSC).
This list also includes transcription factor families that are
located in clusters (such as HOX), as well as those that reside
in different locations (such as FOX, ZIC, GATA, KLF, SIX, TBX,
LHX, and DLX). In addition, genes in DMVs are strongly enriched
for those encoding components of development signaling path-
ways, including WNT, receptor tyrosine kinase (RTK), BMP, and
Hedgehog (Figure 5H). Furthermore, there are 319 lncRNA genes
with promoters that overlap with DMVs, including 22 lncRNA
genes newly identified in this study (Figure 5H and Table S7).
Finally, we found 40 microRNA genes in DMVs (Figure 5H and
Table S7), 12 (30%) of which are known to be hESC specific
(such as mir-302/367) (Suh et al., 2004) or within 10 kb of line-
age-restricted genes that we identified (data not shown). Taken
together, our data have revealed a unique class of genomic re-
gions that show wide depletion of DNA methylation and are
strongly associated with transcription factor genes and develop-
mental genes.
The Majority of DMVs Remain Largely Unmethylated
upon Cell Differentiation
Previously, bivalent genes marked by H3K4me3 and H3K27me3
were shown to be highly enriched for developmental genes
(Bernstein et al., 2006). Interestingly, DMV genes appear to be
more enriched for transcription factors and developmental
genes compared to bivalent genes in hESCs as defined in thisCell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc. 1141
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Figure 5. Genes within DMVs Are Strongly Enriched for Transcription Factors and Developmental Genes
(A) DNA methylation levels for a DMV (GSC) and a nearby typical UMR (CLMN) are shown.
(B) Histograms showing the distribution of the lengths of hypomethylated regions in various cell types.
(C) The numbers of DMVs found in various cell types. The horizontal line indicates the number of DMVs shared by all cell types.
(D) The distribution of lengths of various genomic elements as indicated.
(E) The average conservation level (PhastCons scores) around DMVs.
(F) A Venn diagram showing the overlap of genes with DMVs in humans (H1 and its derived cells) and in mice (frontal cortex).
(G) Gene ontology analysis results for DMV genes in H1 and the H1-derived cells.
(H) A breakdown of the types of DMV genes in H1 and the H1-derived cells, with examples shown in the tables.
See also Figure S5.
1142 Cell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc.
study or previous studies (Pan et al., 2007; Zhao et al., 2007) (Fig-
ures 6A and S6A). Additionally, genes in DMVs are not simply
genes with long CGIs, high promoter CG density, or CGI clusters
(Extended Experimental Procedures) (Figures 6A and S6B). We
then asked whether DMVs undergo dynamic epigenetic regula-
tion upon H1 differentiation. We examined the DNA methylation
levels in H1, the H1-derived cells, and a panel of publishedmeth-
ylomes (see Figure 6D and its legend for the list) (Berman et al.,
2012; Li et al., 2010; Lister et al., 2011). Interestingly, most of the
promoters in DMVs (89.5%, n = 968) remain hypomethylated in
all cell types (Figures 6B and S6C). The other 113 promoters
demonstrate methylation level at or above 0.4 in at least one
cell type (Figures 6B and S6C), including those at several HOX
genes as shown previously (Bock et al., 2012; Laurent et al.,
2010), and genes that have low CG promoters include POU5F1
(Figure 3E), DPPA4 (data not shown), and the hESC-specific mi-
croRNA gene cluster mir-302/367 (Figure 6C). Notably, the
expression of the mir-302/367 cluster can reprogram somatic
cells to pluripotent cells (Anokye-Danso et al., 2011). The activity
of mir-302/367 may be regulated by DNA methylation as indi-
cated by the hypermethylation of the associated DMV upon dif-
ferentiation (Figure 6C). Therefore, a small subset of DMVs,
including those at the HOX genes and a number of CG-poor pro-
moters, shows dynamic DNA methylation during cell
differentiation.
Next, we examined DMVs that remain hypomethylated upon
cell differentiation. Among all 968 coding genes that are located
in these DMVs, 259 are defined as aforementioned lineage-
restricted genes. Most promoters of these genes are CG rich
and are marked differentially by H3K27me3 in various lineages,
while lacking DNA methylation in general (Figure 6D). Addition-
ally, 134 genes are repressed in all six cell types and are also pre-
dominantly marked by H3K27me3, including HOXC5/C12/D3/
D4, FOXB2/D2/D4/E1, andPAX3/5/7 (Figure 6D).We then exam-
ined genes with DMVs that are expressed in most lineages (R4)
in the current study, including those that are marked by
H3K27me3 in at least one of the six cell types, and those that
are not marked by H3K27me3 in any cell types (Figure 6D).
The first group shows somewhat weak lineage-restricted
expression. The second group is active in all six cell types.
Gene ontology analysis shows that this group is not enriched
for housekeeping genes but instead is still strongly enriched for
transcription regulators, such as MYC, MLL, SRF, and CBX3,
and several histone demethylase genes, KDM2A/2B, JARID2,
and JMJD1C. Together, DMV genes appear to be largelymarked
by H3K4me3 and/or H3K27me3 (Figures 6D and 6E). Interest-
ingly, this is also true in sperm as we examined data sets from
published studies (Hammoud et al., 2009; Molaro et al., 2011)
(Figures 6D and 6E). Consistent with the notion that many biva-
lent developmental genes become monovalent upon cell differ-
entiation (Bernstein et al., 2006), a larger portion of DMVs bear
only either H3K4me3 or H3K27me3 in differentiated cells
compared to that in sperm or H1 (Figure 6E). Interestingly, the
sperm genome contains more DMVs than those in other cell
types (n = 4,167), and most DMVs in H1 and the H1-derived cells
(82.9%) are also present in sperm (Figure 6F). These observa-
tions are exemplified at two loci near HAND1 (Figure 6G) and
MYC (Figure 6H). Therefore, we conclude that the majority ofgenes in DMVs remain hypomethylated upon H1 differentiation
and are premarked by H3K27me3 and/or H3K4me3 in sperm.
Genes with DMVs Are Hypermethylated in Cancer
As promoters with DMVs are preferentially hypomethylated in
most cells that we examined, we sought to examine whether
this is also true in cancer. Notably, DMV genes are enriched for
genes involved in cancer pathways (Figure 5H), tumor suppres-
sor genes (n = 120, p value = 23 1020) and oncogenes (n = 72,
p value = 5 3 1014) (Cancer Gene Database, Memorial Sloan-
Kettering Cancer Center) (Table S7). Interestingly, by examining
base-resolution methylomes for normal and tumor colon tissues
(Berman et al., 2012), we found that promoters in DMVs gain sig-
nificant levels of DNAmethylation in the tumor tissue (Figure 7A).
Genome wide, 54.0% of DMVs (n = 659) overlap with the
‘‘methylation-prone elements’’ in colon cancer (Berman et al.,
2012). Conversely, 28.9% of methylation-prone elements (n =
1,493) overlap with DMVs. Because the majority of methyl-
ation-prone elements (71%) are in nonpromoter regions (Berman
et al., 2012), but DMVs are present almost exclusively at pro-
moters, we focused on the promoter regions for the following
analysis. Strikingly, promoters that gain most DNA methylation
in the tumor sample (DmCG/CG R 0.4) strongly overlap with
DMVs identified in H1 and the H1-derived cells (Figures 7B and
7C). This is true for promoters of both coding genes and lncRNA
genes. Similar results were obtained using two additional hyper-
methylated gene lists in breast cancer and colorectal cancer
(Figure S7A). As a control, promoters with DMVs remain hypo-
methylated in blood cells (Figure 7B). Importantly, most hyper-
methylated tumor suppressor genes in colon cancer are also
DMV genes (16/22, p value = 1 3 1017). Unexpectedly, 12 on-
cogenes are also hypermethylated in colon cancer, among
which 9 are DMV genes (p value = 2 3 1011). Previously, it
was shown that many hypermethylated genes in cancer are Pol-
ycomb targets (Bracken and Helin, 2009). Consistently, 87.2%
(575/659) of hypermethylated DMVs, compared to 42% (236/
561) of nonhypermethylated DMVs, are marked by K27me3 in
H1. Taken together, these data suggest that, although DMV pro-
moters are preferentially devoid of DNA methylation in normal
cells, they are prone to hypermethylation in cancer.
DISCUSSION
It has long been recognized that epigenetic mechanisms play a
critical role in mammalian development, but precisely how DNA
methylation and chromatin modifications contribute to develop-
ment has not yet been clearly elucidated. In this study, we
focused on hESCs as a model and generated by far the most
comprehensive reference epigenome maps of a multilineage
differentiation system in humans. Importantly, we demon-
strated that the majority of genes differentially expressed in
early progenitors are CG rich and appear to employ
H3K27me3-mediated repression in nonexpressing cells.
Conversely, genes differentially expressed in later stages are
largely CG poor and preferentially show DNA methylation-medi-
ated gene silencing (Figure 7D). Surprisingly, we found more
than 1,200 loci, termed DNA methylation valleys, that largely
remain unmethylated in most cell types that we examined.Cell 153, 1134–1148, May 23, 2013 ª2013 Elsevier Inc. 1143
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Figure 6. DMVs Largely Remain Hypomethylated in Sperm and Many Terminally Differentiated Cell Types
(A) Percentages of genes that belong to various gene ontology groups are shown as bar graphs for coding genes in DMVs (n = 1,081), genes with longest CGIs
(n = 1,081), genes with the highest promoter CG densities (n = 1,081), genes with CGI clusters (n = 1,019), hESC bivalent genes as defined in this study (n = 2,401)
or in previous studies (Zhao et al., 2007, n = 1,797 after gene symbol conversion; Pan et al., 2007, n = 3,301 after gene symbol conversion), all RefSeq genes,
housekeeping genes (n = 3,140), and somatic-tissue-specific genes (n = 885) as defined in Zhu et al. (2008).
(B) A bar graph showing the percentages of promoters in DMVs that demonstrate dynamic DNA methylation (mCG/CGR 0.4 in any cell types) or constant DNA
methylation (mCG/CG < 0.4 in any cell types).
(C) The levels of DNA methylation and RNA are shown near mir-302A/302B/302C/302D/367. A transcript, likely the hosting transcript for this microRNA gene
cluster, is observed mainly in H1 and ME (only  strand RNA reads are shown for simplicity).
(legend continued on next page)
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AC
D
B Figure 7. DMVs Are Preferentially Methyl-
ated in Cancer
(A) Box plots showing the distribution of the DNA
methylation levels at promoters in DMVs for
various cell types.
(B)Scatterplots showing theDNAmethylation levels
at promoters between colon and blood (left) and
normal and tumor colon (right). Red, promoterswith
DMVs; black, all other promoters in the genome.
(C) Venn diagrams showing the overlaps between
genes of which the promoters are hyper-
methylated in colon cancer (DmCGR 0.4, at least
10 CGs covered) and genes with DMVs for coding
genes (left) and lncRNA genes (right).
(D) A model for three classes of promoters with
distinct sequence features and epigenetic regu-
lation mechanisms in cell differentiation.
See the Discussion for details and also Figure S7.These regions are uniquely enriched for transcription factor and
developmental regulatory genes. Interestingly, DMVs frequently
gain abnormal DNA methylation in cancer, suggesting that al-
terations in DNA methylation machinery might be an important
epigenetic mechanism aiding tumorigenesis. In accordance
with an independent study of human ES cells differentiating to
cells representative of three germ layers (Gifford et al., 2013
[this issue of Cell]), we observed cell-type-specific, dynamic
DNA methylation and H3K27me3 at enhancers during ES cell
differentiation. Our analysis further demonstrated that dynamic
changes of DNA methylation and chromatin marks at en-
hancers correlate with gene expression, suggesting a potential
role of epigenetic modulators in regulating enhancer activities.
Distinct Epigenetic Mechanisms at Lineage-Restricted
Genes Expressed at Early and Late Stages of ES Cell
Differentiation
Previous studies have shown that somatic-tissue-specific pro-
moters tend to be CG poor (Barrera et al., 2008; Schug et al.,
2005). However, we found that a large number of CG-rich pro-(D) Heatmaps showing RNA, H3K27ac, H3K4me3, H3K27me3, and DNA methylation levels for promoters o
levels of DNA methylation in additional 11 cell types and sperm, as well as the levels of H3K4me3 and H3K2
foreskin fibroblast (FF)-derived iPSC lines (19.11,6.9,19.7); 5, adipose-derived stem (ADS) cell iPSCs; 6, FF iP
derived adipocytes; 9, FF (Lister et al., 2011); 10, PMBC (blood) (Li et al., 2010); 11, colon tissue (Berman et
(E) The chromatin state (presence of H3K4me3 and/or H3K27me3) of DMVs is shown for various cell types.
(F) The overlap of DMVs is shown between those in H1 and its derived cells and those in sperm.
(G and H) The epigenetic landscape is shown for the DMV associated with the gene HAND1 (G) or MYC (H)
See also Figure S6.
Cell 153, 1134–11moters appear to drive lineage-specific
expression in hESC-derived early precur-
sor cells. In line with previous studies,
these CG-rich promoters tend to employ
Polycomb, but not DNA methylation, for
repression (Meissner et al., 2008; Men-
denhall et al., 2010; Mohn et al., 2008).
By contrast, dynamic DNA methylation
is frequently observed at the late-stage
lineage-restricted promoters, which arecharacterized by CG-poor sequences. Similar results were ob-
tained when we analyzed two published time course data sets
for single lineage hESC differentiation to trophoblast (Xu et al.,
2002) (Figure S7B) or cardiovascular cells (Paige et al., 2012)
(Figure S7C). Together, these data add to the notion that low
and high CG promoters are regulated by distinct epigenetic reg-
ulatory mechanisms (Meissner et al., 2008) and further suggest a
temporal relationship of DNAmethylation and Polycomb in regu-
lating cell-type-specific genes.
DMVs Are a Special Class of Genomic Loci Subject to
Exquisite Epigenetic Control
Interestingly, many genes encoding for key regulators of embry-
onic development reside in hypomethylated domains, or DMVs.
Importantly, these DMVs are also preferentially hypomethylated
in sperm, raising the possibility that these DMVs may be estab-
lished even earlier. Why are developmental regulatory genes
preferentially located in DMVs? One possibility is that DNA
methylation at these regions may be incompatible with mainte-
nance of the pluripotency or multipotency of these cells. Wef genes with DMVs within various categories. The
7me3 in sperm, are also shown. 1, hESC H9; 2–4,
SC-derived trophoblast-like cells; 7, ADS; 8, ADS-
al., 2012).
.
48, May 23, 2013 ª2013 Elsevier Inc. 1145
noticed that many DMV genes demonstrate a bivalent state
(H3K4me3 and H3K27me3), which is linked to poised transcrip-
tion that may enable developmental genes to be more flexibly
modulated (Bernstein et al., 2006). DNAmethylation, on the other
hand, may be required for more stable silencing of genes in
terminally differentiated cells. Another possibility is that the ge-
netic programs regulating embryonic development may actually
evolve separately from, or prior to, the evolution of DNA methyl-
ation machinery. Supporting this hypothesis, DNAmethylation is
either absent (such as in Drosophila and C. elegans) or varies
considerably in its pattern relative to gene activity in inverte-
brates (Feng et al., 2010; Zemach et al., 2010). On the other
hand, the Polycomb family of factors regulates key develop-
mental regulatory genes in both invertebrates and vertebrates
in amore conservedmanner. Several mechanisms of DNA hypo-
methylation at DMVs can be envisioned. DMVs may be recog-
nized by proteins, such as the Tet family, that actively remove
DNA methylation (Wu and Zhang, 2011). Alternatively, DMVs
may be associated with histone modifications or histone vari-
ants, such as H3K4me3 or H2A.Z, that are incompatible to
DNA methylation (Cedar and Bergman, 2009). Future experi-
ments are needed to determine which of the above mechanisms
could be responsible for DMV formation in the mammalian
genome.
EXPERIMENTAL PROCEDURES
hESC Differentiation
H1 cells were differentiated according to previously established protocols to
mesendoderm (Yu et al., 2011), trophoblast-like cells (Xu et al., 2002), neural
progenitor cells (Chambers et al., 2009; Chen et al., 2011), and mesenchymal
stem cells (Vodyanik et al., 2010). Details of the differentiation methods can be
found in Extended Experimental Procedures.
MethylC-Seq Library Generation and Sequencing
Genomic DNA from H1 and the H1-derived cells was extracted and sonicated.
Sequencing libraries were constructed using NEBNext DNA Sample Prep Re-
agent Set 1 (NEB). Methylated adapters were used in place of the standard
genomic DNA adapters from Illumina. Ligation products were purified, bisulfite
treated, PCR amplified, and sequenced using HiSeq2000 (Illumina).
ChIP-Seq Library Generation and Sequencing
H1 and the H1-derived cells were processed following a ChIP protocol as pre-
viously described (Hawkins et al., 2010). ChIP libraries were prepared and
sequenced using the Illumina instrument per manufacturer’s instructions.
RNA-Seq Library Generation and Sequencing
Total RNA from H1 and the H1-derived cells was extracted and sequencing
libraries were constructed using the TruSeq RNA Sample Prep Kit (Illumina)
(Poly(A) selected) according to manufacturer’s instructions with modifications
to confer strand specificity (seeExtendedExperimental Procedures for details).
ACCESSION NUMBERS
All data have been deposited to the Sequence Read Archive (SRA) under
accession number SRP000941.
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